ChemicalBook > CAS DataBase List > AVL-292

AVL-292

Product Name
AVL-292
CAS No.
1202757-89-8
Chemical Name
AVL-292
Synonyms
CS-733;CC-292;LMK-435;AVL-292;Spebrutinib;AVL-292 >=98%;CC-292,LMK-435;CC-292 (AVL-292);AVL 292 - CC 292;AVL-292 USP/EP/BP
CBNumber
CB02655392
Molecular Formula
C22H22FN5O3
Formula Weight
423.44
MOL File
1202757-89-8.mol
More
Less

AVL-292 Property

Density 
1.322±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
≥21.15 mg/mL in DMSO; insoluble in H2O; ≥4.9 mg/mL in EtOH with gentle warming and ultrasonic
form 
solid
pka
13.22±0.70(Predicted)
color 
White to khaki
InChIKey
KXBDTLQSDKGAEB-UHFFFAOYSA-N
SMILES
C(NC1=CC=CC(NC2C(F)=CN=C(NC3=CC=C(OCCOC)C=C3)N=2)=C1)(=O)C=C
CAS DataBase Reference
1202757-89-8
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
17993
Product name
AVL-292
Purity
≥98%
Packaging
1mg
Price
$44
Updated
2024/03/01
Cayman Chemical
Product number
17993
Product name
AVL-292
Purity
≥98%
Packaging
5mg
Price
$193
Updated
2024/03/01
Cayman Chemical
Product number
17993
Product name
AVL-292
Purity
≥98%
Packaging
10mg
Price
$341
Updated
2024/03/01
Cayman Chemical
Product number
17993
Product name
AVL-292
Purity
≥98%
Packaging
50mg
Price
$957
Updated
2024/03/01
TRC
Product number
A794715
Product name
AVL-292
Packaging
100mg
Price
$610
Updated
2021/12/16
More
Less

AVL-292 Chemical Properties,Usage,Production

Uses

Bruton’s tyrosine kinase (BTK) is a non-receptor tyrosine kinase involved in signal transduction pathways regulating the proliferation, activation, and differentiation of B cells. AVL-292 is an orally available, selective, and irreversible inhibitor of BTK (IC50 = 0.5 nM in vitro in B cell lymphoma cell lines) that targets and covalently binds to BTK at cysteine-481, thereby preventing its activity. AVL-292 has been shown to inhibit osteoclast function and to reduce osteoclast-stimulated proliferation of multiple myeloma cells in animal models of rheumatoid arthritis and multiple sclerosis, both of which are diseases where B cells play an important role. In clinical trials, AVL-292 has demonstrated therapeutic significance in the treatment of both B cell-related cancers (e.g., non-Hodgkin’s lymphoma and B cell chronic lymphocytic leukemia) and autoimmune diseases (e.g., rheumatoid arthritis).[Cayman Chemical]

Synthesis

1202759-91-8

814-68-6

1202757-89-8

N-(3-((5-fluoro-2-((4-(2-methoxyethoxy)phenyl)amino)pyrimidin-4-yl)amino) was synthesized using N4-(3-aminophenyl)-5-fluoro-N2-(4-(2-methoxyethoxy)phenyl)pyrimidin-1,4-diamide (309 mg, 0.84 mmol) and acryloyl chloride (71 μL, 0.88 mmol) as the raw materials. The general procedure for phenyl)acrylamide was as follows: a THF (10 mL) solution of N4-(3-aminophenyl)-5-fluoro-N2-(4-(2-methoxyethoxy)phenyl)pyrimidine-1,4-diamine was cooled in a water/ice-MeOH bath (-10°C). Acryloyl chloride (71 μL, 0.88 mmol) was slowly added to the cooled solution and the reaction was stirred for 10 min. Hunig base (145 μL, 0.88 mmol) was then added and stirring was continued for 10 min. Upon completion of the reaction, the reaction mixture was partitioned between water/brine (10 mL) and the organic layer was separated after thorough stirring. The organic phase was dried with anhydrous sodium sulfate and the solvent was subsequently removed by rotary evaporation. The residue was ground with ether and filtered to give 285 mg of off-white solid product in 80% yield. The product was analyzed by LC/MS with retention time (RT) = 2.79 min and molecular ion peak (M+H)+ m/z = 424.2.

target

Btk

References

[1] Patent: WO2009/158571, 2009, A1. Location in patent: Page/Page column 190; 192
[2] Patent: US2014/179720, 2014, A1. Location in patent: Paragraph 0380; 0383
[3] Patent: US2015/174128, 2015, A1. Location in patent: Paragraph 0629

AVL-292 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

AVL-292 Suppliers

Jinan SanZhi Pharmaceutical Technology Co., Ltd.
Tel
15053191807
Fax
-
Email
sales_sanzhi@163.com
Country
China
ProdList
286
Advantage
55
Shanghai Beckham Medical Technology Co., Ltd
Tel
13816613772
Fax
QQ: 12922499
Email
huahero21@sina.com
Country
China
ProdList
2391
Advantage
55
Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2922
Advantage
55
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6003
Advantage
61
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Fax
+86-25-83453306
Email
info@chemlin.com.cn
Country
China
ProdList
15883
Advantage
64
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Country
China
ProdList
42934
Advantage
64
shanghai Rainbow MediTech.Co.Ltd.
Tel
021-64968085,64968086-5815,5812; 13472757003
Fax
+86 21 64968087
Email
xiaoxia.zeng@rainbowpharma.cn
Country
China
ProdList
961
Advantage
65
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
sales@meilune.com
Country
China
ProdList
4747
Advantage
58
Shanghai Topbiochem Technology Co., Ltd
Tel
021-58170097
Email
info@topbiochem.com
Country
China
ProdList
9510
Advantage
58
NCE Biomedical Co.,Ltd.
Tel
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Fax
+86-27-87599188
Country
China
ProdList
1493
Advantage
55
More
Less

View Lastest Price from AVL-292 manufacturers

Zhejiang J&C Biological Technology Co.,Limited
Product
AVL-292 1202757-89-8
Price
US $0.00/gram
Min. Order
1gram
Purity
99%
Supply Ability
10kg
Release date
2022-02-17
Career Henan Chemical Co
Product
AVL-292 1202757-89-8
Price
US $2.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
100kg
Release date
2018-12-24

1202757-89-8, AVL-292Related Search:


  • AVL-292
  • LMK-435
  • N-[3-[[5-Fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide
  • 2-Propenamide, N-[3-[[5-fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-
  • CC-292 (AVL-292)
  • CC-292,LMK-435
  • N-[3-[[5-Fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide AVL292
  • CC-292
  • Spebrutinib
  • N-(3-((5-fluoroethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acrylamide
  • CS-733
  • N-(3-((5-fluoroethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acrylamide (AVL-292)
  • CC-292; AVL292; AVL-292; AVL 292
  • AVL 292 - CC 292
  • CC-292;AVL292;AVL-292;AVL 292;SPEBRUTINIB
  • AVL-292 (Spebrutinib)
  • AVL-292 >=98%
  • N-(3-((5-fluoro-2-((4-(2-methoxyethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acrylamide
  • Spebrutinib (AVL-292)
  • Spebrutinib (CC-292, AVL-292)
  • N-{3-[(5-Fluoro-2-{[4-(2-methoxyethoxy)phenyl]amino}pyrimidin-4-yl)amino]phenyl}prop-2-enamide
  • AVL-292 USP/EP/BP
  • Spebrutinib (CC292
  • 7-Epoxytropine hydrochloride
  • Spebrutinib, 10 mM in DMSO
  • N-[3-[[5-fluoro-2-[4-(2-methoxyethoxy)anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide
  • Spebrutinib (CC-292) ,S7173
  • 1202757-89-8
  • Inhibitors